COVID-19 features include disseminated intravascular coagulation and thrombotic microangiopathy indicating a hypercoagulable state. We aimed to investigate antiphospholipid antibodies (aPL) prevalence and clinical relationships in a large cohort of COVID-19 patients.

Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases

Gatto, Mariele;
2020-01-01

Abstract

COVID-19 features include disseminated intravascular coagulation and thrombotic microangiopathy indicating a hypercoagulable state. We aimed to investigate antiphospholipid antibodies (aPL) prevalence and clinical relationships in a large cohort of COVID-19 patients.
2020
38
4
754
759
Antibodies; Anticardiolipin; Antibodies; Antiphospholipid; Antiphospholipid Syndrome; Betacoronavirus; Coronavirus Infections; Humans; Immunoglobulin G; Immunoglobulin M; Pandemics; Pneumonia; Viral; Thrombosis; beta 2-Glycoprotein I
Gatto, Mariele; Perricone, Carlo; Tonello, Marta; Bistoni, Onelia; Cattelan, Anna Maria; Bursi, Roberto; Cafaro, Giacomo; De Robertis, Edoardo; Mencacci, Antonella; Bozza, Silvia; Vianello, Andrea; Iaccarino, Luca; Gerli, Roberto; Doria, Andrea; Bartoloni, Elena
File in questo prodotto:
File Dimensione Formato  
article (1).pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 596.49 kB
Formato Adobe PDF
596.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1939912
Citazioni
  • ???jsp.display-item.citation.pmc??? 43
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 50
social impact